Table A2.
Correlation between carbapenemase phenotype and antimicrobial susceptibility.
| Antimicrobial Agent | Carbapenemase Producer | p Value | ||
|---|---|---|---|---|
| No | Yes | |||
| Number (%) | Number (%) | |||
| AMC | Not susceptible | 26 (24.5) | 3 (100) | 0.017 |
| Susceptible | 80 (75.5) | 0 | ||
| ATM | Not susceptible | 10 (9.4) | 2 (66.7) | 0.032 |
| Susceptible | 96 (90.6) | 1 (33.3) | ||
| CTX | Not susceptible | 13 (12.3) | 2 (66.7) | 0.049 |
| Susceptible | 93 (87.7) | 1 (33.3) | ||
| CAZ | Not susceptible | 9 (8.5) | 2 (66.7) | 0.026 |
| Susceptible | 97 (91.5) | 1 (33.3) | ||
| ZOX | Not susceptible | 10 (9.4) | 2 (66.7) | 0.032 |
| Susceptible | 96 (90.6) | 1 (33.3) | ||
| CRO | Not susceptible | 13 (12.3) | 2 (66.7) | 0.049 |
| Susceptible | 93 (87.7) | 1 (33.3) | ||
| AM | Not susceptible | 103 (97.2) | 3 (100) | 0.919 |
| Susceptible | 3 (2.8) | 0 | ||
| CIP | Not susceptible | 16 (15.1) | 2 (66.7) | 0.070 |
| Susceptible | 90 (84.9) | 1 (33.3) | ||
| LEV | Not susceptible | 15 (14.2) | 2 (66.7) | 0.063 |
| Susceptible | 91 (85.8) | 1 (33.3) | ||
| F | Not susceptible | 2 (1.9) | 0 | 0.945 |
| Susceptible | 104 (98.1) | 3 (100) | ||
| SXT | Not susceptible | 43 (40.6) | 3 (100) | 0.072 |
| Susceptible | 63 (59.4) | 0 | ||
| TGC | Susceptible | 106 (100) | 3 (100) | NA |
| DOR | Susceptible | 106 (100) | 3 (100) | NA |
| ETP | Not susceptible | 5 (4.7) | 0 | 0.867 |
| Susceptible | 101 (95.3) | 3 (100) | ||
| IPM | Susceptible | 106 (100) | 3 (100) | NA |
| MEM | Susceptible | 106 (100) | 3 (100) | NA |
Notes: Percentage is calculated within the column of each antimicrobial agent. NA: p value could not be computed. AMC: Amoxicillin/clavulanic acid. ZOX: Ceftizoxime. CAZ: Ceftazidime. CRO: Ceftriaxone. CTX: Cefotaxime. ATM: Aztreonam. AM: Ampicillin. SXT: Sulfamethoxazole/trimethoprim. F: Nitrofurantoin. LEV: Levofloxacin. CIP: Ciprofloxacin. TGC: Tigecycline. IPM: Imipenem. MEM: Meropenem. ETP: Ertapenem. DOR: Doripenem.